Company Profile
Ironwood Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- IRWD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Ironwood Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
3.86 USD (+1.05%)
Close
Last updated: June 23, 2026 at 00:00
635.41M USD
Market cap
Why the stock is moving
IRWD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Ironwood Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Ironwood Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Ironwood Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Ironwood Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)
Source: Ironwood Pharmaceuticals
- 02
- 03
Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2B Studies
Source: Ironwood Pharmaceuticals
- 04
Microbia Appoints Halley Gilbert as Vice President, General Counsel
Source: Ironwood Pharmaceuticals
- 05
Microbia Announces Name Change to Ironwood Pharmaceuticals
Source: Ironwood Pharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ironwood Pharmaceuticals (IRWD)?
Ironwood Pharmaceuticals (IRWD) most recently closed at 3.86 USD, a +1.05% move versus the previous session.
What is the market cap of Ironwood Pharmaceuticals (IRWD)?
Ironwood Pharmaceuticals currently has a market capitalization of 635.41M USD on BioPharmSignal.
What does Ironwood Pharmaceuticals do?
Ironwood Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is IRWD stock listed?
Ironwood Pharmaceuticals (IRWD) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Ironwood Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Ironwood?
Ironwood Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Ironwood Pharmaceuticals targeting with Ironwood?
Ironwood Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Ironwood Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.